Article Information
History
- February 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Department of Diagnostic Physics, Oslo University Hospital, Oslo, Norway
- 2Department of Psychology, University of Oslo, Oslo, Norway
- 3Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 4BioMolecular Imaging, LLC, Baltimore, Maryland, USA
- ↵* Corresponding author; email: m.o.trostheim{at}psykologi.uio.no
Posted February 28, 2022.
Opioid Antagonism in Humans: A Primer on Optimal Dose and Timing for Central Mu-Opioid Receptor Blockade
